Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer

NCT02581215 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: mFOLFIRINOX
DRUG: Ramucirumab
OTHER: Placebo

Sponsor

Walid Shaib, MD

Collaborators

[object Object]
[object Object]